Publication details

Jak interpretovat účinnost léčby novými antitrombotiky ve výsledcích laboratorních testů

Title in English How to interpret efficacy of treatment with new antithrombotics in results of laboratory tests
Authors

MICHALCOVÁ Jana BULIKOVÁ Alena ZAVŘELOVÁ Jiřina ŠTĚPAŘOVÁ Andrea PENKA Miroslav

Year of publication 2017
Type Article in Periodical
Magazine / Source Postgraduální medicína
MU Faculty or unit

Faculty of Medicine

Citation
Field Oncology and hematology
Keywords DOAC; dabigatran; rivaroxaban; apixaban; edoxaban; laboratory examination
Description Introducing direct peroral anticoagulants into clinical practice brings a substantial advance in anticoagulation therapy and it has indisputable benefits compared to the traditional treatment with vitamin K antagonists. At the samé time, this modern treatment has its possible pitfalls, such as interpre-tation of coagulation tests. In patients using direct anticoagulants it is usually not necessary to monitor the treatment regularly, but in some cases, a laboratory examination of coagulation rates is necessary. It is also necessary to keep in mind that these preparations can influence a whole range of both routine and speciál coagulation tests, which always needs to be kept in mind when interpreting results.
Related projects: